Blue Ant............I think the drop in SP since 20th has been a result of the addition to the MSCI Index now. Brokers/traders knowing this date was coming pushed the price down to get a heap of cheap shares that would have a guarrantee of going up on inclusion into the Index.
Some shorters may have taken the opportunity to close positions.
This afternoon will be interesting with a Friday/weekend close so which way will the SP go? Demand ready for Monday? or sell for the weekend.
For me I don't care less as I am mostly on a LTH position. I am more interested in seeing a continuation of buying/volume to confirm a re-Rate.
The stuff I have posted regarding Renesas and potential income for 2022 should not be under estimated. Smarter people than us are watching and will know how this must play out with the SP and MC. Any revenue from Renesas chip of even just $1 Billon will have a dramatic re-rate of the SP beyond what most here can comprehend. Think PE. Think big boyz who base so much on PE. enough said.
Yak52
- Forums
- ASX - By Stock
- BRN
- Ann: AGM Address and Presentation
Ann: AGM Address and Presentation, page-526
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online